Pituitary macroadenoma in a patient with POEMS syndrome in conjunction with Castleman disease: first report of a case and review of related literature.
Endocr Pract., 16(1):97-101 (2010)
Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.
Clin Ther., Jul;31(7):1511-23 (2009)
The complexity of reproductive decisions for patients with advanced cancer: ethical and communicative dimensions.
J Support Oncol., 8(1):45-8 (2010)
Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance.
Diabetologia., Apr;45(4):509-17 (2002)
Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.
Diabetes., Jan;50(1):150-8 (2001)
Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models.
Am. J. Physiol. Endocrinol. Metab., Jan;280(1):E2-10 (2001)
Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
J. Clin. Invest., Aug;106(3):329-33 (2000)
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Diabetes Care., Jan;22(1):141-6 (1999)
Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.
J. Clin. Invest., Aug;100(3):530-7 (1997)
Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
J. Clin. Endocrinol. Metab., Feb;82(2):524-30 (1997)
Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
J. Clin. Endocrinol. Metab., Jul;82(7):2108-16 (1997)